Septerna Inc
NASDAQ:SEPN

Watchlist Manager
Septerna Inc Logo
Septerna Inc
NASDAQ:SEPN
Watchlist
Price: 21.67 USD -0.55% Market Closed
Market Cap: 966.3m USD

EV/EBIT
Enterprise Value to EBIT

-6
Current
-1.9
Median
16.4
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-6
=
Enterprise Value
611.7m USD
/
EBIT
-102.2m USD
Market Cap EV/EBIT
US
Septerna Inc
NASDAQ:SEPN
962.6m USD -6
US
Eli Lilly and Co
NYSE:LLY
781.6B USD 36.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
458.3B USD 19.6
CH
Roche Holding AG
SIX:ROG
215.9B CHF 11.8
UK
AstraZeneca PLC
LSE:AZN
194.3B GBP 170.5
CH
Novartis AG
SIX:NOVN
201.5B CHF 14.8
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 11.1
US
Merck & Co Inc
NYSE:MRK
220.1B USD 10.2
IE
Endo International PLC
LSE:0Y5F
195.2B USD 777.4
US
Pfizer Inc
NYSE:PFE
140.8B USD 10.2
EBIT Growth EV/EBIT to Growth
US
Septerna Inc
NASDAQ:SEPN
Average EV/EBIT: 1 876.4
Negative Multiple: -6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.2
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
19.6
14%
1.4
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
UK
AstraZeneca PLC
LSE:AZN
170.5
22%
7.7
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
11.1
6%
1.9
US
Merck & Co Inc
NYSE:MRK
10.2
9%
1.1
IE
E
Endo International PLC
LSE:0Y5F
777.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
10%
1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-46.2
2-Years Forward
EV/EBIT
-4.8
3-Years Forward
EV/EBIT
-3.3